1. Home
  2. AWF vs COLL Comparison

AWF vs COLL Comparison

Compare AWF & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWF
  • COLL
  • Stock Information
  • Founded
  • AWF 1993
  • COLL 2002
  • Country
  • AWF United States
  • COLL United States
  • Employees
  • AWF N/A
  • COLL N/A
  • Industry
  • AWF Trusts Except Educational Religious and Charitable
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • AWF Finance
  • COLL Health Care
  • Exchange
  • AWF Nasdaq
  • COLL Nasdaq
  • Market Cap
  • AWF 956.3M
  • COLL 958.8M
  • IPO Year
  • AWF N/A
  • COLL 2015
  • Fundamental
  • Price
  • AWF $10.89
  • COLL $33.22
  • Analyst Decision
  • AWF
  • COLL Strong Buy
  • Analyst Count
  • AWF 0
  • COLL 4
  • Target Price
  • AWF N/A
  • COLL $44.25
  • AVG Volume (30 Days)
  • AWF 190.0K
  • COLL 347.0K
  • Earning Date
  • AWF 01-01-0001
  • COLL 11-06-2025
  • Dividend Yield
  • AWF 7.57%
  • COLL N/A
  • EPS Growth
  • AWF N/A
  • COLL N/A
  • EPS
  • AWF N/A
  • COLL 1.06
  • Revenue
  • AWF N/A
  • COLL $707,007,000.00
  • Revenue This Year
  • AWF N/A
  • COLL $22.23
  • Revenue Next Year
  • AWF N/A
  • COLL $2.78
  • P/E Ratio
  • AWF N/A
  • COLL $31.05
  • Revenue Growth
  • AWF N/A
  • COLL 22.61
  • 52 Week Low
  • AWF $9.20
  • COLL $23.23
  • 52 Week High
  • AWF $10.67
  • COLL $39.95
  • Technical
  • Relative Strength Index (RSI)
  • AWF 30.15
  • COLL 42.31
  • Support Level
  • AWF $10.93
  • COLL $31.26
  • Resistance Level
  • AWF $11.02
  • COLL $35.83
  • Average True Range (ATR)
  • AWF 0.10
  • COLL 0.96
  • MACD
  • AWF -0.03
  • COLL -0.12
  • Stochastic Oscillator
  • AWF 4.60
  • COLL 42.89

About AWF Alliancebernstein Global High Income Fund

Alliancebernstein Glb High Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its primary investment objective is to seek high current income, and secondarily, capital appreciation. The fund invests in debt securities, including Sovereign Debt Obligations and corporate debt, denominated in non-U.S. currencies as well as in the U.S. Dollar. It may invest without limit in emerging and developed markets and debt securities of U.S. and non-U.S. corporate issuers.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: